Your browser doesn't support javascript.
loading
A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial.
Zhu, Jiemin; Ebert, Lyn; Liu, Xiangyu; Chan, Sally Wai-Chi.
Afiliação
  • Zhu J; Nursing Department, Medical College of Xiamen University, Xiangan Nan road, Xiangan District, Xiamen city, Fujian Province, 361102, People's Republic of China. Jiemin.zhu@uon.edu.au.
  • Ebert L; School of Nursing and Midwifery, Faculty of Health and Medicine, University of Newcastles, Richardson Wing, Callaghan University Drive, Callaghan, NSW, 2308, Australia. Jiemin.zhu@uon.edu.au.
  • Liu X; School of Nursing and Midwifery, Faculty of Health and Medicine, University of Newcastles, Richardson Wing, Callaghan University Drive, Callaghan, NSW, 2308, Australia.
  • Chan SW; Hunan Cancer Hospital, the affiliated cancer hospital of Xiangya School of Medicine, Central South University, 283 Tongzipo Road, Yuelu District, Changsha, Hunan, 410013, People's Republic of China.
BMC Cancer ; 17(1): 291, 2017 04 26.
Article em En | MEDLINE | ID: mdl-28446141
BACKGROUND: Women with breast cancer undergoing chemotherapy suffer from a number of symptoms and report receiving inadequate support from health care professionals. Innovative and easily accessible interventions are lacking. Breast Cancer e-Support is a mobile Application program (App) that provides patients with individually tailored information and a support group of peers and health care professionals. Breast Cancer e-Support aims to promote women's self-efficacy, social support and symptom management, thus improving their quality of life and psychological well-being. METHODS: A single-blinded, multi-centre, randomised, 6-month, parallel-group superiority design will be used. Based on Bandura's self-efficacy theory and the social exchange theory, Breast Cancer e-Support has four modules: 1) a Learning forum; 2) a Discussion forum; 3) an Ask-the-Expert forum; and 4) a Personal Stories forum. Women with breast cancer (n = 108) who are commencing chemotherapy will be recruited from two university-affiliated hospitals in China. They will be randomly assigned to either control group that receives routine care or intervention group that receives routine care plus access to Breast Cancer e-Support program during their four cycles of chemotherapy. Self-efficacy, social support, symptom distress, quality of life, and anxiety and depression will be measured at baseline, then one week and 12 weeks post-intervention. DISCUSSION: This is the first study of its kind in China to evaluate the use of a mobile application intervention with a rigorous research design and theoretical framework. This study will contribute to evidence regarding the effectiveness of a theory-based mobile application to support women with breast cancer undergoing chemotherapy. The results should provide a better understanding of the role of self-efficacy and social support in reducing symptom distress and of the credibility of using a theoretical framework to develop internet-based interventions. The results will provide evidence to support the implementation of an innovative and easily accessible intervention that enhances health outcomes. TRIAL REGISTRATION: ACTRN: ACTRN12616000639426 , Registered 17 May, 2016.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apoio Social / Neoplasias da Mama / Telemedicina / Autoeficácia / Aplicativos Móveis Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Limite: Adult / Female / Humans País/Região como assunto: Asia Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apoio Social / Neoplasias da Mama / Telemedicina / Autoeficácia / Aplicativos Móveis Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Limite: Adult / Female / Humans País/Região como assunto: Asia Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article